Abstract
Since the US FDA-approval of the first immune checkpoint inhibitor, anticytotoxic T-lymphocyte antigen-4 monoclonal antibody ipilimumab, for metastati......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
